| |
| |
|
| Insider
Information: |
Opaleye Management Inc. |
| Relationship: |
10% Owner |
| City: |
Cambridge |
| State: |
MA |
| |
|
| Insider
Summary: |
|
|
|
|
Companies Owned : |
6 |
|
| Direct
Shares |
0 |
|
|
Indirect Shares
|
11,359,363 |
|
|
| Direct
Value |
$0 |
|
|
|
Indirect Value
|
$66,817,571 |
|
|
| Total
Shares |
11,359,363 |
|
|
| Total
Value |
$66,817,571 |
|
|
|
|
|
|
|
|
Historical
Performance :
Based on 6 Month Return Percentages |
Buys
|
Sells
|
|
Total
Filings :
|
123
|
5
|
|
Stock
price went up :
|
64
|
3
|
| Stock
price went down : |
59
|
2
|
| |
|
|
|
Gain/Loss Ratio : |
1.1
|
1.5
|
| Percentage
Gain/Loss : |
 14.2%
|
 -54.2%
|
| |
|
|
|
|
|
Holdings
:
| Menu |
Company Name |
Ticker |
Relation |
Direct Date |
Direct Shares |
Indirect Date |
Indirect Shares |
Total Value Sold  |
 |
Harrow Health Inc |
HROW |
10% Owner |
2015-05-19 |
0 |
2024-04-25 |
3,815,000 |
Premium* |
|
|
Ocular Therapeutix, Inc |
OCUL |
10% Owner |
|
0 |
2020-01-02 |
4,918,500 |
Premium* |
|
|
Eton Pharmaceuticals, Inc. |
ETON |
10% Owner |
|
0 |
2021-11-17 |
2,375,000 |
Premium* |
|
|
Tracon Pharmaceuticals, Inc. |
TCON |
10% Owner |
2020-08-27 |
0 |
2023-11-10 |
0 |
Premium* |
|
|
Protara Therapeutics, Inc |
TARA |
10% Owner |
2020-09-24 |
0 |
2024-05-17 |
126,050 |
Premium* |
|
|
Tela Bio, Inc. |
TELA |
10% Owner |
2022-06-10 |
0 |
2022-11-03 |
124,813 |
Premium* |
|
|
|
|
|
|
|
|
|
|
|
Records found :
158 |
Free Registration Required For Full Results. Limit: 25
|
 |
Download |
Page 3 of 7
|
| Ticker |
Company Name |
Relation |
Off-Dir-10% |
Trans. Date |
Form |
Action |
Price |
Mkt Value |
D/I |
Shares |
Holdings |
Rank
|
|
|
| 3m +/- |
|
|
Form |
| TCON |
Tracon Pharmaceuticals, I... |
10% Owner |
– – • |
2020-09-04 |
4 |
B |
$2.88 |
$26,130 |
I/I |
9,058 |
1,664,438 |
1.5 |
% |
|
| TCON |
Tracon Pharmaceuticals, I... |
10% Owner |
– – • |
2021-12-27 |
4 |
B |
$2.92 |
$255,103 |
I/I |
87,325 |
265,000 |
1.5 |
% |
|
| TARA |
Protara Therapeutics, Inc |
10% Owner |
– – • |
2024-05-17 |
4 |
S |
$3.06 |
$230,326 |
I/I |
(70,885) |
126,050 |
0 |
% |
|
| TARA |
Protara Therapeutics, Inc |
10% Owner |
– – • |
2024-05-09 |
4 |
S |
$3.09 |
$94,526 |
I/I |
(30,600) |
2,531,994 |
0 |
% |
|
| TARA |
Protara Therapeutics, Inc |
10% Owner |
– – • |
2024-05-10 |
4 |
S |
$3.11 |
$472,424 |
I/I |
(151,700) |
2,380,294 |
0 |
% |
|
| TCON |
Tracon Pharmaceuticals, I... |
10% Owner |
– – • |
2020-09-09 |
4 |
B |
$3.47 |
$164,773 |
I/I |
47,500 |
1,709,438 |
1.5 |
% |
|
| HROW |
Harrow Health Inc |
10% Owner |
– – • |
2016-03-11 |
4 |
B |
$3.65 |
$164,250 |
I/I |
45,000 |
1,250,000 |
1.5 |
- |
|
| TARA |
Protara Therapeutics, Inc |
10% Owner |
– – • |
2022-09-15 |
4 |
B |
$3.80 |
$27,740 |
I/I |
7,300 |
132,300 |
1.5 |
% |
|
| OCUL |
Ocular Therapeutix, Inc |
10% Owner |
– – • |
2020-01-02 |
4 |
B |
$3.90 |
$58,508 |
I/I |
15,000 |
4,918,500 |
1.5 |
- |
|
| OCUL |
Ocular Therapeutix, Inc |
10% Owner |
– – • |
2019-12-30 |
4 |
B |
$3.97 |
$79,410 |
I/I |
20,000 |
207,500 |
1.5 |
- |
|
| TARA |
Protara Therapeutics, Inc |
10% Owner |
– – • |
2022-09-14 |
4 |
B |
$3.98 |
$66,068 |
I/I |
16,600 |
130,000 |
1.5 |
% |
|
| TCON |
Tracon Pharmaceuticals, I... |
10% Owner |
– – • |
2020-10-21 |
4 |
B |
$4.40 |
$38,060 |
I/I |
8,656 |
1,797,094 |
1.5 |
% |
|
| TCON |
Tracon Pharmaceuticals, I... |
10% Owner |
– – • |
2020-09-24 |
4 |
B |
$4.44 |
$95,648 |
I/I |
21,534 |
1,785,438 |
1.5 |
% |
|
| HROW |
Harrow Health Inc |
10% Owner |
– – • |
2020-05-20 |
4 |
B |
$4.47 |
$6,739 |
I/I |
1,500 |
119,800 |
1.5 |
% |
|
| HROW |
Harrow Health Inc |
10% Owner |
– – • |
2020-05-21 |
4 |
B |
$4.66 |
$49,338 |
I/I |
10,596 |
120,000 |
1.5 |
% |
|
| ETON |
Eton Pharmaceuticals, Inc... |
10% Owner |
– – • |
2021-11-17 |
4 |
S |
$4.67 |
$116,713 |
I/I |
(25,000) |
2,375,000 |
0 |
- |
|
| TARA |
Protara Therapeutics, Inc |
10% Owner |
– – • |
2022-04-07 |
4 |
B |
$4.74 |
$11,123 |
I/I |
2,345 |
125,031 |
1.5 |
% |
|
| ETON |
Eton Pharmaceuticals, Inc... |
10% Owner |
– – • |
2021-11-15 |
4 |
S |
$4.80 |
$14,405 |
I/I |
(3,000) |
85,938 |
0 |
- |
|
| TARA |
Protara Therapeutics, Inc |
10% Owner |
– – • |
2022-04-08 |
4 |
B |
$4.80 |
$37,364 |
I/I |
7,791 |
128 |
1.5 |
% |
|
| HROW |
Harrow Health Inc |
10% Owner |
– – • |
2020-07-09 |
4 |
B |
$4.82 |
$145,079 |
I/I |
30,000 |
130,000 |
1.5 |
% |
|
| TCON |
Tracon Pharmaceuticals, I... |
10% Owner |
– – • |
2020-09-23 |
4 |
B |
$4.83 |
$276,448 |
I/I |
57,200 |
1,764,438 |
1.5 |
% |
|
| ETON |
Eton Pharmaceuticals, Inc... |
10% Owner |
– – • |
2021-11-16 |
4 |
S |
$4.86 |
$60,472 |
I/I |
(12,438) |
85,000 |
0 |
- |
|
| HROW |
Harrow Health Inc |
10% Owner |
– – • |
2020-07-11 |
4 |
B |
$4.96 |
$231,922 |
I/I |
46,800 |
2,808,100 |
1.5 |
% |
|
| TARA |
Protara Therapeutics, Inc |
10% Owner |
– – • |
2022-01-28 |
4 |
B |
$4.96 |
$119,271 |
I/I |
24,031 |
124,031 |
1.5 |
% |
|
| HROW |
Harrow Health Inc |
10% Owner |
– – • |
2020-07-10 |
4 |
B |
$4.98 |
$223,965 |
I/I |
45,000 |
2,761,300 |
1.5 |
% |
|
158 Records found
|
|
Page 3 of 7 |
| |
Free Registration Required For Full Results. Limit: 25
|
|
| |
Transaction Code Key: |
Ownership Code Key |
| |
B |
- Buy |
AB |
- Automatic Buy |
D |
- Direct Ownership |
| |
S |
- Sell |
AS |
- Automatic Sell |
I |
- Indirect Ownership |
|
OE |
- Options Exercised |
A |
- Aquired |
| |
IO |
- Initital Ownership |
D |
- Disposed |
| |
|
|
|
|
|
